Max Kurlbaum
Impact in
-
- Hormonal Regulation and Hypertension
- Adrenal Hormones and Disorders
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Adrenal Hormones and Disorders 10
- Hormonal Regulation and Hypertension 4
- Surgery 21
- Adrenal and Paraganglionic Tumors 18
- Bariatric Surgery and Outcomes 3
- Co-authors
- Martin Faßnacht (24 shared papers)Matthias Kroiß (17 shared papers)Petra Högger (2 shared papers)Timo Deutschbein (7 shared papers)Oliver Scherf‐Clavel (11 shared papers)Sabine Kendl (9 shared papers)Graeme Eisenhofer (5 shared papers)Stefanie Hahner (8 shared papers)
- Journals
- European Journal of Endocrinology (5 papers)Journal of Pharmaceutical and Biomedical Analysis (3 papers)Frontiers in Endocrinology (3 papers)International Journal of Molecular Sciences (2 papers)Therapeutic Drug Monitoring (2 papers)
- Partner nations
- GermanyNetherlandsSwitzerland
In The Last Decade
Max Kurlbaum
42 papers receiving 835 citations
Max Kurlbaum's Hit Papers
Peers
Comparison fields: 5 of 73
- Endocrinology, Diabetes and Metabolism 163
- Pharmacology 141
- Analytical Chemistry 72
- Surgery 253
- Applied Microbiology and Biotechnology 13
Countries citing papers authored by Max Kurlbaum
This map shows the geographic impact of Max Kurlbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Kurlbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Kurlbaum more than expected).
Fields of papers citing papers by Max Kurlbaum
This network shows the impact of papers produced by Max Kurlbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Kurlbaum. The network helps show where Max Kurlbaum may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Kurlbaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial Hit paper breakdown → | 2022 | 137 |
| 2 | 2018 | 66 | |
| 3 | 2018 | 64 | |
| 4 | 2021 | 62 | |
| 5 | 2020 | 51 | |
| 6 | 2010 | 41 | |
| 7 | 2020 | 35 | |
| 8 | 2021 | 31 | |
| 9 | 2013 | 28 | |
| 10 | 2015 | 23 | |
| 11 | 2019 | 23 | |
| 12 | 2021 | 23 | |
| 13 | 2020 | 21 | |
| 14 | 2019 | 16 | |
| 15 | 2020 | 16 | |
| 16 | 2016 | 14 | |
| 17 | 2016 | 14 | |
| 18 | 2023 | 14 | |
| 19 | 2018 | 13 | |
| 20 | 2021 | 13 |
About Max Kurlbaum
Max Kurlbaum is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Analytical Chemistry, Pharmacology and Pharmacology, having authored 48 papers that have together received 850 indexed citations. Recurring topics across this work include Adrenal and Paraganglionic Tumors (18 papers), Adrenal Hormones and Disorders (10 papers), Analytical Methods in Pharmaceuticals (6 papers), Pharmacogenetics and Drug Metabolism (5 papers), Hormonal Regulation and Hypertension (4 papers), Biosimilars and Bioanalytical Methods (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Bariatric Surgery and Outcomes (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (163 citations), Pharmacology (141 citations), Analytical Chemistry (72 citations), Surgery (253 citations) and Applied Microbiology and Biotechnology (13 citations). Max Kurlbaum has collaborated with scholars based in Germany, Netherlands and Switzerland. Frequent co-authors include Martin Faßnacht, Matthias Kroiß, Petra Högger, Timo Deutschbein, Oliver Scherf‐Clavel, Sabine Kendl, Graeme Eisenhofer, Stefanie Hahner, Mirko Peitzsch and Aleksander Prejbisz. Their work appears in journals such as European Journal of Endocrinology, Journal of Pharmaceutical and Biomedical Analysis, Frontiers in Endocrinology, International Journal of Molecular Sciences and Therapeutic Drug Monitoring.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.